Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

  • Yasuto Akiyama1Email author,
  • Chie Oshita1,
  • Akiko Kume1,
  • Akira Iizuka1,
  • Haruo Miyata1,
  • Masaru Komiyama1,
  • Tadashi Ashizawa1,
  • Mika Yagoto1,
  • Yoshiaki Abe4,
  • Koichi Mitsuya2,
  • Reiko Watanabe3,
  • Takashi Sugino3,
  • Ken Yamaguchi1 and
  • Yoko Nakasu2
BMC Cancer201212:623

DOI: 10.1186/1471-2407-12-623

Received: 22 August 2012

Accepted: 17 December 2012

Published: 27 December 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
22 Aug 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 Sep 2012 Reviewed Reviewer Report - Hideho Okada
26 Oct 2012 Reviewed Reviewer Report - Wenyin Shi
5 Dec 2012 Author responded Author comments - Yasuto Akiyama
Resubmission - Version 3
5 Dec 2012 Submitted Manuscript version 3
13 Dec 2012 Reviewed Reviewer Report - Hideho Okada
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
17 Dec 2012 Editorially accepted
27 Dec 2012 Article published 10.1186/1471-2407-12-623

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Immunotherapy Division, Shizuoka Cancer Center Research Institute
(2)
Division of Neurosurgery, Shimonagakubo, Shizuoka Cancer Center Hospital
(3)
Division of Diagnostic Pathology, Shimonagakubo, Shizuoka Cancer Center Hospital
(4)
Division of blood stem cell transplantation, Shizuoka Cancer Center Hospital, Shimonagakubo

Advertisement